Equities

Coltene Holding AG

Coltene Holding AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)51.80
  • Today's Change-1.00 / -1.89%
  • Shares traded4.16k
  • 1 Year change-27.86%
  • Beta1.0025
Data delayed at least 15 minutes, as of May 06 2024 16:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.

  • Revenue in CHF (TTM)242.73m
  • Net income in CHF11.95m
  • Incorporated2005
  • Employees1.20k
  • Location
    Coltene Holding AGFeldwiesenstrasse 20ALTSTAETTEN 9450SwitzerlandCHE
  • Phone+41 717575380
  • Fax+41 717575301
  • Websitehttps://www.coltene.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Onward Medical NV0.00-35.31m164.59m99.00--8.20-----1.20-1.200.000.5940.00----0.00-60.19-55.70-68.71-61.60-------79,513.95---58.040.4848---34.62---10.40--32.59--
Prim SA211.31m12.37m166.28m900.0013.421.357.500.78690.7450.74512.737.401.121.994.10240,567.406.586.689.248.9037.9338.115.856.431.22--0.1681--9.7710.0051.02-2.1412.86--
Bactiguard Holding AB18.50m-10.57m187.28m191.00--7.35--10.12-3.60-3.606.309.800.30354.286.001,017,544.00-17.35-7.56-19.82-8.8129.8747.91-57.15-26.281.64-11.900.4129---11.966.46-161.71--8.43--
Sedana Medical AB (publ)13.82m-1.91m188.93m83.00--2.2833,161.0213.67-0.2299-0.22991.669.950.15641.248.102,087,443.00-2.17-5.77-2.28-6.0870.5064.06-13.85-36.137.38--0.0043--25.2321.5918.90--42.12--
Detection Technology Oyj-97.60bn-97.60bn225.29m478.00--3.17----------4.97----------9.34--11.96--47.44--8.223.13--0.08153.455.292.027.55-18.03-14.88-9.55
Semperit Holding AG703.77m24.53m232.92m4.58k9.450.56113.820.3311.23-0.816235.1720.670.80984.688.24157,578.902.795.253.607.3222.4624.793.455.591.384.920.342686.85-7.54-3.87-34.59---7.21--
Tristel Plc44.96m6.87m250.25m213.0036.817.0425.695.570.12560.12560.82190.65670.9921.516.26185,394.4015.178.8617.1010.2482.5980.6315.2910.633.93411.730.1605109.9915.7010.14351.986.409.8818.05
Nyxoah SA4.24m-42.18m262.96m147.00--2.75--61.96-1.55-1.550.15553.420.03220.78912.0629,618.53-31.98-23.73-35.88-25.9861.9162.42-993.86-1,469.594.50--0.1147--40.99---38.39--100.58--
BICO Group AB188.51m-142.17m268.31m884.00--0.6701--1.42-23.61-27.6631.6069.180.24872.243.062,545,136.00-18.77---20.89--52.34---75.47--1.91-1.050.2852--6.09---1,889.33------
Medistim ASA44.40m8.58m270.71m152.0031.507.5225.536.105.605.6029.0123.481.030.77656.153,492,704.0019.9522.9324.0728.5279.0278.2519.3120.642.99--0.020675.257.0010.06-8.9112.720.03314.87
Lumibird SA198.67m6.95m280.67m1.05k35.961.4811.751.410.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
COLTENE Holding AG242.73m11.95m315.51m1.20k26.383.2616.791.302.002.0040.6216.211.331.406.58201,937.606.5310.4810.9018.7464.2462.684.927.470.80455.620.317279.94-9.133.54-54.05-6.81-7.72-7.79
IVF Hartmann Holding AG147.95m15.15m331.20m304.0021.872.1916.022.246.316.3161.6363.070.80153.088.46486,687.508.217.299.998.9053.9053.2910.248.303.89--0.005652.16-1.792.0934.951.49-14.8326.82
Ion Beam Applications SA418.43m-8.89m406.09m1.99k--3.77172.570.9705-0.3139-0.313914.723.640.7022.542.73215,869.60-1.491.55-5.924.3231.3635.23-2.122.380.71031.400.281443.0718.6710.74-250.40---8.06--
Avon Protection PLC221.28m-14.89m419.85m928.00--2.98105.131.90-0.4359-0.38276.484.100.70052.635.48209,434.20-4.71-1.07-5.39-1.2935.2335.51-6.73-1.621.802.920.3822---7.481.85-387.72---1.66-7.86
CellaVision AB59.34m11.83m452.65m223.0038.267.1229.707.635.925.9229.6931.810.7571.688.453,106,469.0015.0915.3017.3418.2467.5269.0319.9419.982.2166.290.0688110.185.9413.1710.128.0030.458.45
Data as of May 06 2024. Currency figures normalised to Coltene Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

14.59%Per cent of shares held by top holders
HolderShares% Held
UBS Asset Management Switzerland AGas of 31 Dec 2022186.78k3.13%
Credit Suisse Asset Management (Schweiz) AGas of 05 Apr 2023179.07k3.00%
Tweedy, Browne Co. LLCas of 29 Dec 2023148.68k2.49%
Reichmuth & Co.as of 30 Jun 202365.00k1.09%
Dimensional Fund Advisors LPas of 04 Apr 202460.89k1.02%
L�hiTapiola Varainhoito Oyas of 31 Mar 202456.24k0.94%
Fourton Fund Management Co. Ltd.as of 30 Jun 202352.00k0.87%
Z�rcher Kantonalbank (Investment Management)as of 29 Feb 202450.13k0.84%
Discover Capital GmbHas of 30 Jun 202340.00k0.67%
LLB Asset Management AGas of 29 Feb 202432.97k0.55%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.